Charles Randall, MD | |
260 Merrimac St, Newburyport, MA 01950-2192 | |
(978) 499-7200 | |
(978) 499-7216 |
Full Name | Charles Randall |
---|---|
Gender | Male |
Speciality | Internal Medicine - Pulmonary Disease |
Location | 260 Merrimac St, Newburyport, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881699668 | NPI | - | NPPES |
A59300 | Other | NH | ANTHEM BLUE CROSS |
0014413 | Other | CIGNA | |
110045489A | Medicaid | MA | |
974558 | Other | MA | NETWORK HEALTH |
60720 | Other | MA | HARVARD PILGRIM HEALTHCAR |
J07241 | Other | MA | BLUE CROSS BLUE SHIELD |
48-00612 | Other | MA | EVERCARE |
054597 | Other | MA | TUFTS HEALTH PLAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 54597 (Massachusetts) | Primary |
207R00000X | Internal Medicine | 54597 (Massachusetts) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Charles Randall, MD 260 Merrimac St, Newburyport, MA 01950-2192 Ph: (978) 499-7200 | Charles Randall, MD 260 Merrimac St, Newburyport, MA 01950-2192 Ph: (978) 499-7200 |
News Archive
Many aspects of pediatric cardiology are relatively new to the discipline. Only recently have physicians been able to accurately diagnose and characterize the myriad congenital cardiovascular conditions that occur and begin to apply successful strategies for care.
Northwest Biotherapeutics, a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, announced today that Brad Silver, an All American swimming and water polo athlete who was diagnosed with Glioblastoma multiforme brain cancer in late 2002, and was treated with DCVax-L in March of 2003, just celebrated the 10th anniversary of his continued cancer-free survival.
Researchers at Dana-Farber Cancer Institute have received a $5.6 million grant from the Defense Advanced Research Projects Agency (DARPA) and the Army Research Office (ARO) to develop transient immunity against known, unknown, naturally occurring, or engineered disease-causing pathogens. The ultimate goal is to develop a viable countermeasure to an unknown pathogen within seven days of receiving it in a laboratory.
A wide range of airborne substances can cause respiratory problems for asthma sufferers. These include bacteria and their components, which can trigger inflammations.
› Verified 7 days ago
Luis Alberto Quiel Cojocaru, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 25 Highland Ave, Newburyport, MA 01950 Phone: 978-463-1383 | |
Isaac Pourati, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 260 Merrimac St, Newburyport, MA 01950 Phone: 978-499-7400 Fax: 978-499-7335 | |
Dr. Viktoria A. Shvets, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 21 Highland Ave, Annajaques Hospital, Newburyport, MA 01950 Phone: 978-463-7770 | |
Maria Ratchkova, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 25 Highland Ave, Ajh Hospitalist Program, Newburyport, MA 01950 Phone: 978-463-1383 | |
Dr. Peter J Sebeny, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 21 Highland Ave Ste 5, Newburyport, MA 01950 Phone: 978-255-4886 Fax: 978-255-4878 | |
Sharman Gingrich, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 25 Highland Ave, Newburyport, MA 01950 Phone: 978-914-5189 Fax: 978-463-1386 | |
Dr. Michael J Mccartney, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 18 Highland Ave, Newburyport, MA 01950 Phone: 978-462-9571 Fax: 978-462-1459 |